Literature DB >> 2552095

What influences doctors' prescribing? Sore throats revisited.

J Pitts, S Vincent.   

Abstract

An audit of two practices in 1987 revealed a wide range of antibiotic prescribing for acute sore throat among the general practitioners. The data were presented at a postgraduate meeting and recommendations were made for a practice policy on antibiotic prescribing. The results of studies that looked at the objectives of treatment were included at that meeting. This paper presents a re-evaluation of the same doctors' antibiotic prescribing one-year later. Changes had occurred in the range and costs of drugs chosen, but individual doctors' prescribing rates remained broadly similar, in other words it was easier to influence what, but not whether, a doctor prescribes for this clinical condition. The existence of a prescribing 'threshold' within the individual doctor is supported.

Mesh:

Substances:

Year:  1989        PMID: 2552095      PMCID: PMC1711733     

Source DB:  PubMed          Journal:  J R Coll Gen Pract        ISSN: 0035-8797


  10 in total

1.  Variation in general practitioners' referral rates to consultants.

Authors:  D Wilkin; A G Smith
Journal:  J R Coll Gen Pract       Date:  1987-08

2.  Diagnostic labels, treatment and outcome in acute sore throat.

Authors:  J Pitts; S H Vincent
Journal:  Practitioner       Date:  1988-03-22

3.  Personal factors as a cause of differences in prescribing by general practitioners.

Authors:  C R Joyce; J M Last; M Weatherall
Journal:  Br J Prev Soc Med       Date:  1968-07

4.  Self-audit of prescribing habits and clinical care in general practice.

Authors:  M G Sheldon
Journal:  J R Coll Gen Pract       Date:  1979-12

5.  Penicillin in sore throat.

Authors:  M J Whitfield; A O Hughes
Journal:  Practitioner       Date:  1981-02

6.  Do general practitioners have different "referral thresholds"?

Authors:  R O Cummins; B Jarman; P M White
Journal:  Br Med J (Clin Res Ed)       Date:  1981-03-28

7.  Antibiotics, sore throats and rheumatic fever.

Authors:  J G Howie; B A Foggo
Journal:  J R Coll Gen Pract       Date:  1985-05

8.  Prescribing--a case for prolonged treatment.

Authors:  C M Harris; J Fry; B Jarman; E Woodman
Journal:  J R Coll Gen Pract       Date:  1985-06

9.  An audit of prescribing by peer review.

Authors:  P M Reilly; M P Patten
Journal:  J R Coll Gen Pract       Date:  1978-09

10.  Antibiotics, sore throats and acute nephritis.

Authors:  J L Taylor; J G Howie
Journal:  J R Coll Gen Pract       Date:  1983-12
  10 in total
  7 in total

1.  Influence of prescription patterns in general practice on anti-microbial resistance in Norway.

Authors:  M Lindbaek; D Berild; J Straand; P Hjortdahl
Journal:  Br J Gen Pract       Date:  1999-06       Impact factor: 5.386

Review 2.  Pharmacoeconomics of antibacterial treatment.

Authors:  P G Davey; M M Malek; S E Parker
Journal:  Pharmacoeconomics       Date:  1992-06       Impact factor: 4.981

3.  Action thresholds.

Authors:  J Pitts; M Whitby
Journal:  Br J Gen Pract       Date:  1990-08       Impact factor: 5.386

4.  Rates and costs of prescribing.

Authors: 
Journal:  Occas Pap R Coll Gen Pract       Date:  1991-11

Review 5.  Sore throats.

Authors:  H Marcovitch
Journal:  Arch Dis Child       Date:  1990-03       Impact factor: 3.791

6.  Association between guidelines and medical practitioners' perception of best management for patients attending with an apparently uncomplicated acute sore throat: a cross-sectional survey in five countries.

Authors:  Ronny Gunnarsson; Mark H Ebell; Hannelore Wächtler; Naveen Manchal; Lynne Reid; Stefan Malmberg; Sean Hawkey; Alastair D Hay; Katarina Hedin; Pär-Daniel Sundvall
Journal:  BMJ Open       Date:  2020-09-17       Impact factor: 2.692

7.  What is the optimal strategy for managing primary care patients with an uncomplicated acute sore throat? Comparing the consequences of nine different strategies using a compilation of previous studies.

Authors:  Ronny Gunnarsson; Ulrich Orda; Bradley Elliott; Clare Heal; Chris Del Mar
Journal:  BMJ Open       Date:  2022-04-29       Impact factor: 3.006

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.